# Skin bioMARkers for Atopic Eczema Therapy Evaluation

> **NCT04194814** · PHASE2 · COMPLETED · sponsor: **Sheffield Teaching Hospitals NHS Foundation Trust** · enrollment: 37 (actual)

## Conditions studied

- Atopic Eczema/Dermatitis (Non-Specific)

## Interventions

- **DRUG:** crisaborole (2%) ointment
- **DRUG:** betamethasone valerate 0.1% cream

## Key facts

- **NCT ID:** NCT04194814
- **Lead sponsor:** Sheffield Teaching Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-20
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2025-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04194814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04194814, "Skin bioMARkers for Atopic Eczema Therapy Evaluation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04194814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*